Zoetis Inc. Share Price Xetra

Equities

ZOE

US98978V1035

Pharmaceuticals

Real-time Estimate Tradegate 02:49:25 03/06/2024 pm IST 5-day change 1st Jan Change
156.4 EUR +0.54% Intraday chart for Zoetis Inc. +0.26% -11.86%

Financials

Sales 2024 * 915.22Cr 844.34Cr 76TCr Sales 2025 * 976.66Cr 901.03Cr 81TCr Capitalization 7.74TCr 7.14TCr 6,43200Cr
Net income 2024 * 251.1Cr 231.65Cr 21TCr Net income 2025 * 276.2Cr 254.81Cr 23TCr EV / Sales 2024 * 8.91 x
Net Debt 2024 * 417.53Cr 385.2Cr 35TCr Net Debt 2025 * 348.59Cr 321.59Cr 29TCr EV / Sales 2025 * 8.28 x
P/E ratio 2024 *
31 x
P/E ratio 2025 *
28.1 x
Employees 14,100
Yield 2024 *
1.02%
Yield 2025 *
1.16%
Free-Float 90.81%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.54%
1 week+0.26%
Current month+0.50%
1 month+0.21%
3 months-9.69%
6 months-6.70%
Current year-11.86%
More quotes
1 week
155.54
Extreme 155.54
158.60
1 month
152.00
Extreme 152
160.90
Current year
136.70
Extreme 136.7
185.00
1 year
136.70
Extreme 136.7
185.00
3 years
131.38
Extreme 131.38
221.00
5 years
113.98
Extreme 113.98
221.00
10 years
113.98
Extreme 113.98
221.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 01/12/01
Director of Finance/CFO 52 01/21/01
Chief Tech/Sci/R&D Officer - 01/11/01
Members of the board TitleAgeSince
Chairman 71 01/13/01
Director/Board Member 73 01/13/01
Director/Board Member 74 01/13/01
More insiders
Date Price Change Volume
03/24/03 156.3 +0.50% 62
31/24/31 155.5 -0.93% 1
30/24/30 157 -1.01% 130
29/24/29 158.6 +1.26% 107
28/24/28 156.6 +0.45% 296

Delayed Quote Xetra, June 03, 2024 at 01:49 pm IST

More quotes
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%); - livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%); - other (1.1%). Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%). At the end of 2022, the group has 29 production sites worldwide. The United States accounts for 53.4% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
169.6 USD
Average target price
211.2 USD
Spread / Average Target
+24.56%
Consensus